Minerva Neurosciences, Inc.
Public company- Headquarters
- BURLINGTON, Massachusetts
- Ticker
- NERV
- CIK
- 0001598646
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Accounting Officer and principal accounting officerAnthony Aliquo | Aug 12, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive appointment
Chief Accounting Officer and principal accounting officer appointed: Anthony Aliquo
Anthony Aliquo was named Chief Accounting Officer and principal accounting officer of Minerva Neurosciences, Inc., effective August 10, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 12, 2026Role: Chief Accounting Officer and principal accounting officer
Only one public record so far. We add events as soon as a new filing lands; watch Minerva Neurosciences, Inc. to get them in your digest.
Last verified Nov 8, 2026